Healthcare | October 10, 2024
WHO declares India has eliminated Trachoma as a public health problem in 2024
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
The product is expected to be launched in Q3FY25
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Stable profits, low leverage to keep credit profiles comfortable
Sanofi would not manufacture or market any product which infringes the amended claims of Panacea patent, IN272351
Subscribe To Our Newsletter & Stay Updated
